MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.16
+0.25 (2.29%)
At close: Nov 26, 2025, 4:00 PM EST
10.94
-0.22 (-1.97%)
After-hours: Nov 26, 2025, 6:48 PM EST
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $52.39 million as of November 26, 2025. Its market cap has increased by 76.66% in one year.
Market Cap
52.39M
Enterprise Value
43.83M
1-Year Change
76.66%
Ranking
Category
Stock Price
$11.16
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $52.39M, a decrease of -86.44%. That is a compound annual growth rate of -38.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 52.39M | 89.68% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | 386.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |